{
    "info": {
        "nct_id": "NCT04513028",
        "official_title": "Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma",
        "inclusion_criteria": "* Any patients with suspected (clinical) or definitive (tissue) diagnosis of Stage III-IV melanoma starting or continuing adjuvant Pembrolizumab without active evidence of disease (NED).\n* Must be treatment na誰ve or have had treatment no less than 6 months prior to enrollment\n* 18 years or older\n* Must be able to take pills\n* ECOG performance status of 0-3\n* Ability to understand and willingness to sign a written informed consent\n* Members of all racial and ethnic groups are eligible for this study\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* History of hypersensitivity reactions attributed to beta-glucan\n* Patients receiving continuous or other ongoing immunosuppressive therapy\n* Uncontrolled intercurrent illness including, but not limited to, autoimmune diseases, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements\n* Any patients who have serious autoimmune toxicity during the study period, or those who have disease recurrence during the 6-week study period should be excluded and analyzed separately\n* Patients with mucosal melanoma\n* Patients with concurrent malignancy or recent history thereof",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Any patients with suspected (clinical) or definitive (tissue) diagnosis of Stage III-IV melanoma starting or continuing adjuvant Pembrolizumab without active evidence of disease (NED).",
            "criterions": [
                {
                    "exact_snippets": "suspected (clinical) or definitive (tissue) diagnosis of Stage III-IV melanoma",
                    "criterion": "melanoma diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis_status",
                            "expected_value": [
                                "suspected (clinical)",
                                "definitive (tissue)"
                            ]
                        },
                        {
                            "requirement_type": "stage",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 3,
                                        "unit": "stage"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 4,
                                        "unit": "stage"
                                    }
                                ]
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "starting or continuing adjuvant Pembrolizumab",
                    "criterion": "adjuvant Pembrolizumab treatment",
                    "requirements": [
                        {
                            "requirement_type": "treatment_status",
                            "expected_value": [
                                "starting",
                                "continuing"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "without active evidence of disease (NED)",
                    "criterion": "active evidence of disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Must be treatment na誰ve or have had treatment no less than 6 months prior to enrollment",
            "criterions": [
                {
                    "exact_snippets": "Must be treatment na誰ve",
                    "criterion": "prior treatment",
                    "requirements": [
                        {
                            "requirement_type": "treatment history",
                            "expected_value": "treatment na誰ve"
                        }
                    ]
                },
                {
                    "exact_snippets": "have had treatment no less than 6 months prior to enrollment",
                    "criterion": "prior treatment",
                    "requirements": [
                        {
                            "requirement_type": "time since last treatment",
                            "expected_value": {
                                "operator": ">=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* 18 years or older",
            "criterions": [
                {
                    "exact_snippets": "18 years or older",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Must be able to take pills",
            "criterions": [
                {
                    "exact_snippets": "Must be able to take pills",
                    "criterion": "ability to take pills",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* ECOG performance status of 0-3",
            "criterions": [
                {
                    "exact_snippets": "ECOG performance status of 0-3",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 3,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Ability to understand and willingness to sign a written informed consent",
            "criterions": [
                {
                    "exact_snippets": "Ability to understand",
                    "criterion": "cognitive ability",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "willingness to sign a written informed consent",
                    "criterion": "willingness to sign informed consent",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Members of all racial and ethnic groups are eligible for this study",
            "criterions": [
                {
                    "exact_snippets": "Members of all racial and ethnic groups are eligible",
                    "criterion": "racial and ethnic group",
                    "requirements": [
                        {
                            "requirement_type": "membership",
                            "expected_value": "any"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Patients with mucosal melanoma",
            "criterions": [
                {
                    "exact_snippets": "Patients with mucosal melanoma",
                    "criterion": "mucosal melanoma",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients with concurrent malignancy or recent history thereof",
            "criterions": [
                {
                    "exact_snippets": "Patients with concurrent malignancy",
                    "criterion": "concurrent malignancy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "recent history thereof",
                    "criterion": "recent history of malignancy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": "recent"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients receiving continuous or other ongoing immunosuppressive therapy",
            "criterions": [
                {
                    "exact_snippets": "Patients receiving continuous or other ongoing immunosuppressive therapy",
                    "criterion": "immunosuppressive therapy",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": [
                                "continuous",
                                "ongoing"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of hypersensitivity reactions attributed to beta-glucan",
            "criterions": [
                {
                    "exact_snippets": "History of hypersensitivity reactions attributed to beta-glucan",
                    "criterion": "hypersensitivity reactions to beta-glucan",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any patients who have serious autoimmune toxicity during the study period, or those who have disease recurrence during the 6-week study period should be excluded and analyzed separately",
            "criterions": [
                {
                    "exact_snippets": "serious autoimmune toxicity during the study period",
                    "criterion": "autoimmune toxicity",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "serious"
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "during the study period"
                        }
                    ]
                },
                {
                    "exact_snippets": "disease recurrence during the 6-week study period",
                    "criterion": "disease recurrence",
                    "requirements": [
                        {
                            "requirement_type": "timing",
                            "expected_value": "during the 6-week study period"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Uncontrolled intercurrent illness including, but not limited to, autoimmune diseases, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements",
            "criterions": [
                {
                    "exact_snippets": "Uncontrolled intercurrent illness including, but not limited to, autoimmune diseases",
                    "criterion": "autoimmune diseases",
                    "requirements": [
                        {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                },
                {
                    "exact_snippets": "ongoing or active infection",
                    "criterion": "infection",
                    "requirements": [
                        {
                            "requirement_type": "activity status",
                            "expected_value": "ongoing or active"
                        }
                    ]
                },
                {
                    "exact_snippets": "symptomatic congestive heart failure",
                    "criterion": "congestive heart failure",
                    "requirements": [
                        {
                            "requirement_type": "symptom status",
                            "expected_value": "symptomatic"
                        }
                    ]
                },
                {
                    "exact_snippets": "unstable angina pectoris",
                    "criterion": "angina pectoris",
                    "requirements": [
                        {
                            "requirement_type": "stability",
                            "expected_value": "unstable"
                        }
                    ]
                },
                {
                    "exact_snippets": "cardiac arrhythmia",
                    "criterion": "cardiac arrhythmia",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "psychiatric illness/social situations that would limit compliance with study requirements",
                    "criterion": "psychiatric illness or social situations limiting compliance",
                    "requirements": [
                        {
                            "requirement_type": "impact on compliance",
                            "expected_value": "would limit compliance with study requirements"
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}